Browsing by Contributors Verstovsek, Srdan

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
آ ب پ ت ث ج چ ح خ د ذ ر ز ژ س ش ص ض ط ظ ع غ ف ق ک گ ل م ن و ه ی
 
Showing results 1 to 7 of 7
PreviewIssue DateTitleContributor(s)
2012Heterodimeric JAK-STAT Activation as a Mechanism of Persistence to JAK2 Inhibitor TherapyKoppikar, Priya; Bhagwat, Neha; Kilpivaara, Outi; Manshouri, Taghi; Adli, Mazhar; Hricik, Todd; Liu, Fan; Saunders, Lindsay M.; Mullally, Ann; Abdel-Wahab, Omar; Leung, Laura; Weinstein, Abby; Marubayashi, Sachie; Goel, Aviva; Gönen, Mithat; Estrov, Zeev; Ebert, Benjamin L.; Chiosis, Gabriela; Nimer, Stephen D.; Bernstein, Bradley E.; Verstovsek, Srdan; Levine, Ross L.
2016 JPHO Volume 38 Issue 9 December (31).pdf.jpg2016L ABORATORY O BSERVATIONS A Rare Case of Primary Myelofibrosis in a 14-Year-Old Patient With Congenital AspleniaKhan, Maliha; Yin, Cheng C; Yates, Amber; Newberry, Kate J; Verstovsek, Srdan
JPHO 2017 Volume 39 Issue 4 May (29).pdf.jpg2017L ABORATORY O BSERVATIONS A Rare Case of Primary Myelofibrosis in a 14-Year-Old Patient With Congenital AspleniaKhan, Maliha; Yin, Cheng C; Yates, Amber; Newberry, Kate J; Verstovsek, Srdan
2017 BJH Volume 130 Issue 15 October (15).pdf.jpg2017Letters to Blood To the editor :Verstovsek, Srdan; Passamonti, Francesco; Rambaldi, Alessandro; Barosi, Giovanni; Rumi, Elisa; Gattoni, Elisabetta; Pieri, Lisa; Zhen, Huiling; Granier, Muriel; Assad, Albert; Cazzola, Mario; Kantarjian, Hagop M; Barbui, Tiziano
2016 AJCP olume 145 Issue 3 March (22).pdf.jpg2016Myeloproliferative Neoplasms With Calreticulin Mutations Exhibit Distinctive Morphologic FeaturesLoghavi, Sanam; Bueso-ramos, Carlos E; Kanagal-shamanna, Rashmi; Ok, Chi Young; Salim, Alaa A; Routbort, Mark J; Mehrotra, Meenakshi; Verstovsek, Srdan; Medeiros, L Jeffrey; Luthra, Rajyalakshmi; Patel, Keyur P; Sam, C M E
2017 BJH Volume 130 Issue 2 July (10).pdf.jpg2017Perspective JAK2 inhibitors for myeloproliferative neoplasms : what is next ?Bose, Prithviraj; Verstovsek, Srdan
426.pdf.jpg29-Jan-2015Ruxolitinib versus standard therapy for the treatment of polycythemia veraVannucchi, Alessandro M; Kiladjian, Jean Jacques; Griesshammer, Martin; Masszi, Tamas; Durrant, Simon; Passamonti, Francesco; Harrison, Claire N; Pane, Fabrizio; Zachee, Pierre; Mesa, Ruben; He, Shui; Jones, Mark M; Garrett, William; Li, Jingjin; Pirron, Ulrich; Habr, Dany; Verstovsek, Srdan